BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Siemens Healthineers Launches MAMMOMAT B.brilliant to Advance Early Breast Cancer Detection in Indonesia

Breast cancer remains one of the leading health concerns in Indonesia and ranks as the third deadliest cancer after lung and liver cancer. According to the...

May 02, 2025 | News

HistoIndex Raises S$9M to Accelerate AI-Powered Digital Pathology and Launch of FibroSIGHT™

HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) di...

May 02, 2025 | News

AstraZeneca and Qure.ai Hit 5 Million AI-Enabled Chest X-Rays Milestone Across LMICs

AstraZeneca, in partnership with health-tech company Qure.ai, announced the successful completion of 5 million artificial intelligence (AI) enabled chest X...

May 01, 2025 | News

SimonMed Partners with Lunit to Advance AI-Powered Breast Cancer Detection Across the U.S.

SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce thei...

April 24, 2025 | News

Roche Survey Calls for Immediate Action as Asia Pacific Faces Worsening Vision Health Crisis

Asia Pacific bears nearly two-thirds of the global burden of moderate-to-severe vision impairment. Although 90 percent of vision impairment is preventable ...

April 24, 2025 | News

Eisai and Biogen’s Leqembi® Secures First-of-Its-Kind EU Authorization for Early Alzheimer’s

Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi® (...

April 21, 2025 | News

China Rises as Global Force in Blood Purification Tech at BPPC Annual Conference

Blood Purification Professional Committee (BPPC) of the China Medical Device Industry Association (CMDIA) gathered in Liuyang, Hunan, for its annual c...

April 21, 2025 | News

Akeso Secures NMPA Approval for Ebdarokimab in Moderate-to-Severe Plaque Psoriasis

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, ...

April 21, 2025 | News

Singapore’s T Cell Diagnostics Licenses Duke-NUS Technology to Develop Rapid Point-of-Care T-Cell Assays

T Cell Diagnostics Pte. Ltd. ("TCD") has licensed an intellectual property (IP) and its related know-how from Duke-NUS Medical School to develop point-of-c...

April 18, 2025 | News

Brain Navi Initiates IPO Counseling with First Securities to Accelerate Growth in AI-Driven Surgical Robotics

Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward acce...

April 18, 2025 | News

Clarity Pharmaceuticals Secures Commercial-Scale Copper-64 Supply Agreement with Nusano Ahead of U.S. Product Launch

Clarity has signed a commercial-scale agreement with Nusano, Inc. ("Nusano") for supply of copper-64 (Cu-64 or 64Cu) isotope. The 190,000 squa...

April 18, 2025 | News

Fangzhou Launches AI-Driven Hepatitis Training Center with Guangdong Institute at Liver Disease Forum 2025

Fangzhou Inc., a leader in AI-driven healthcare solutions, partnered with the Guangdong Provincial Liver Disease Institute at the 2025 Greater Bay Area Int...

April 17, 2025 | News

Clarity Begins Phase II Dosing in SECuRE Trial for Prostate Cancer with Enhanced 67Cu-SAR-bisPSMA Formulation

The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GB...

April 16, 2025 | News

XellSmart Receives IND Approval from FDA for iPSC-Derived Cell Therapy in Parkinson’s Disease

In January 2025 (U.S. time), the U.S. Food and Drug Administration (FDA) officially approved the Investigational New Drug (IND) application submi...

April 16, 2025 | News

Stay Connected